Trial Profile
Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 04 Dec 2015 New trial record